APA (7th ed.) Citation

Li, J., Liang, Y., Feng, W., Deng, L., Fang, H., Ji, C., . . . Guo, L. Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study. Wolters Kluwer.

Chicago Style (17th ed.) Citation

Li, Jingyi, et al. Equivalence of SYN008 Versus Omalizumab in Patients with Refractory Chronic Spontaneous Urticaria: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled Phase III Study. Wolters Kluwer.

MLA (9th ed.) Citation

Li, Jingyi, et al. Equivalence of SYN008 Versus Omalizumab in Patients with Refractory Chronic Spontaneous Urticaria: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled Phase III Study. Wolters Kluwer.